This trial has demonstrated how a group of willing and dedicated investigators, supported by a committed CRO, can develop towards total compliance with ICH GCP.

- Director Clinical Operations, Leading North American Bio Tech Company.

The auditor feels that the "Project Management" structure also gives a real focus to the management process, and would be acceptable to most sponsor companies worldwide.

- Vice President, Research and Development Leading European pharmaceutical Company.

The monitoring at this site appears to have been well done. The site personnel are very happy to work with SIRO as they find them to be accessible and unfailingly courteous.

- Audit Team from a North American Pharmaceutical Company.

Apart from the professionalism demonstrated in delivering results, the sheer responsiveness to our concerns and the attitude towards providing proactive solutions, made the experience of working with this SIRO team an absolute delight. We look forward to a successful submission, and certainly to working with SIRO again.

- Manager, Clinical Operations. Leading Canadian Biotech Company.

Both of the investigators have had extensive experience in clinical trials run to ICH GCP guidelines and FDA regulations. In spite of this the project team has taken great care to ensure that the investigators and their teams have been properly trained in all aspects of this study. It was apparent to the auditors that this training had been effective in helping the study to run smoothly and with a minimum of problems.

- Director Clinical Operations, Leading North American Bio Tech Company.

One of the reasons that I recommend SIRO is that their DM project managers have both the technical competence and the medical judgment when they handle clinical data. I cannot find this when I work with other CROs, data managements companies and other ITES. To me I think this is something that you should be proud of

-Principal Scientist
Top 5 Global Pharma.